Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

70 Periodical Search Results

You searched for "c-erbb-2" OR "genes, erbb-2" OR "receptor, erbb-2" within European Journal of Cancer

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-20  of 70 results   Next 20>

Results Page:  [1]  2  3  4

display abstract citation download email a colleague
Display:

  1. c-erbB-3 protein expression in ductal carcinoma in situ of the breast
    L.G. Bobrow, R.R. Millis, L.C. Happerfield, W.J. Gullick
    European Journal of Cancer
    October 1997 (Vol. 33, Issue 11, Pages 1846-1850)
    Abstract | Abstract + References | Full-Text PDF (747 KB)

  1. Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia
    H.Y.S Ngan, S.S Liu, H Yu, K.L Liu, A.N.Y Cheung
    European Journal of Cancer
    October 1999 (Vol. 35, Issue 10, Pages 1546-1550)
    Abstract | Full Text | Full-Text PDF (147 KB)

  1. Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast
    T. Perin, V. Canzonieri, S. Massarut, E. Bidoli, C. Rossi, M. Roncadin, A. Carbone
    European Journal of Cancer
    June 1996 (Vol. 32, Issue 7, Pages 1148-1155)
    Abstract | Abstract + References | Full-Text PDF (1915 KB)

  1. The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer
    A. Webb, P. Scott-Mackie, D. Cunningham, A. Norman, J. Andreyev, M. O'Brien, J. Bensted
    European Journal of Cancer
    January 1996 (Vol. 32, Issue 1, Pages 63-68)
    Abstract | Abstract + References | Full-Text PDF (730 KB)

  1. p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast
    M. Rudas, R. Neumayer, M.F.X. Gnant, M. Mittelböck, R. Jakesz, A. Reiner
    European Journal of Cancer
    January 1997 (Vol. 33, Issue 1, Pages 39-44)
    Abstract | Abstract + References | Full-Text PDF (738 KB)

  1. c-erbB-2 Positivity is a factor for poor prognosis in breast cancer and poor response to hormonal or chemotherapy treatment in advanced disease
    A Jukkola, R Bloigu, Y Soini, E.-R Savolainen, K Holli, G Blanco
    European Journal of Cancer
    February 2001 (Vol. 37, Issue 3, Pages 347-354)
    Abstract | Full Text | Full-Text PDF (135 KB)

  1. Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics
    A Ringberg, L Anagnostaki, H Anderson, I Idvall, M Fernö, for the South Sweden Breast Cancer Group
    European Journal of Cancer
    August 2001 (Vol. 37, Issue 12, Pages 1514-1522)
    Abstract | Full Text | Full-Text PDF (133 KB)

  1. A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients
    E Rahko, G Blanco, Y Soini, R Bloigu, A Jukkola
    European Journal of Cancer
    March 2003 (Vol. 39, Issue 4, Pages 447-453)
    Abstract | Full Text | Full-Text PDF (138 KB)

  1. C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer
    J Sjöström, J Collan, K von Boguslawski, K Franssila, N.-O Bengtsson, I Mjaaland, P Malmström, B Østenstad, E Wist, V Valvere, J Bergh, D Skiöld-Petterson, E Saksela, C Blomqvist
    European Journal of Cancer
    March 2002 (Vol. 38, Issue 4, Pages 535-542)
    Abstract | Full Text | Full-Text PDF (130 KB)

  1. Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment
    B. Linderholm, J. Andersson, B. Lindh, L. Beckman, M. Erlanson, K. Edin, B. Tavelin, K. Grankvist, R. Henriksson
    European Journal of Cancer
    January 2004 (Vol. 40, Issue 1, Pages 33-42)
    Abstract | Full Text | Full-Text PDF (249 KB)

  1. Prediction of response to primary chemotherapy for operable breast cancer
    M Colleoni, E Orvieto, F Nolé, L Orlando, I Minchella, G Viale, G Peruzzotti, C Robertson, C Noberasco, V Galimberti, V Sacchini, P Veronesi, S Zurrida, R Orecchia, A Goldhirsch
    European Journal of Cancer
    April 1999 (Vol. 35, Issue 4, Pages 574-579)
    Abstract | Full Text | Full-Text PDF (74 KB)

  1. Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low values
    S Koscielny, Ph Terrier, A Daver, J Wafflart, J Goussard, G Ricolleau, C Delvincourt, J.C Delarue
    European Journal of Cancer
    March 1998 (Vol. 34, Issue 4, Pages 476-481)
    Abstract | Full Text | Full-Text PDF (91 KB)

  1. Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy
    T. Aas, S. Geisler, G.E. Eide, D.F. Haugen, J.E. Varhaug, A.M. Bassøe, T. Thorsen, H. Berntsen, A.-L. Børresen-Dale, L.A. Akslen, P.E. Lønning
    European Journal of Cancer
    March 2003 (Vol. 39, Issue 4, Pages 438-446)
    Abstract | Full Text | Full-Text PDF (189 KB)

  1. c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer
    O. Stål, S. Sullivan, S. Wingren, L. Skoog, L.E. Rutqvist, J.M. Carstensen, B. Nordenskjöld
    European Journal of Cancer
    December 1995 (Vol. 31, Issue 13, Pages 2185-2190)
    Abstract | Abstract + References | Full-Text PDF (627 KB)

  1. The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile
    M.-C Mathieu, R Rouzier, A Llombart-Cussac, L Sideris, S Koscielny, J.P Travagli, G Contesso, S Delaloge, M Spielmann
    European Journal of Cancer
    February 2004 (Vol. 40, Issue 3, Pages 342-351)
    Abstract | Full Text | Full-Text PDF (329 KB)

  1. EACR-18: the best of European cancer research
    V. Jendrossek, R.J. White
    European Journal of Cancer
    December 2004 (Vol. 40, Issue 18, Pages 2645-2658)
    Abstract | Full Text | Full-Text PDF (319 KB)

  1. Do we need better prognostic factors in node-negative breast cancer? Pro:
    C Thomssen, F Jänicke
    European Journal of Cancer
    February 2000 (Vol. 36, Issue 3, Pages 293-298)
    Full Text | Full-Text PDF (175 KB)

  1. Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometry
    I. Brotherick, B.K. Shenton, M. Egan, W.E. Cunliffe, D.A. Browell, L.G. Lunt, J.R. Young, M.J. Higgs
    European Journal of Cancer
    December 1996 (Vol. 32, Issue 13, Pages 2334-2341)
    Abstract | Abstract + References | Full-Text PDF (973 KB)

  1. Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer
    G Kristiansen, Y Yu, S Petersen, O Kaufmann, K Schlüns, M Dietel, I Petersen
    European Journal of Cancer
    June 2001 (Vol. 37, Issue 9, Pages 1089-1095)
    Abstract | Full Text | Full-Text PDF (1026 KB)

  1. Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing’s sarcoma
    Katia Scotlandi, Maria C. Manara, Claudia M. Hattinger, Stefania Benini, Stefania Perdichizzi, Michela Pasello, Gaetano Bacci, Licciana Zanella, Franco Bertoni, Piero Picci, Massimo Serra
    European Journal of Cancer
    June 2005 (Vol. 41, Issue 9, Pages 1349-1361)
    Abstract | Full Text | Full-Text PDF (2343 KB) | Add-Ons
display abstract citation download email a colleague
Display:

  Viewing 1-20  of 70 results   Next 20>

Results Page:  [1]  2  3  4

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.